Cornerstone Capital Management Holdings’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $943K | Sell |
27,502
-2,800
| -9% | -$96K | 0.01% | 908 |
|
|
2017
Q3 | $1.1M | Sell |
30,302
-4,800
| -14% | -$173K | 0.01% | 911 |
|
|
2017
Q2 | $906K | Sell |
35,102
-1,194
| -3% | -$30.8K | 0.01% | 930 |
|
|
2017
Q1 | $696K | Sell |
36,296
-109,504
| -75% | -$2.1M | 0.01% | 996 |
|
|
2016
Q4 | $2.43M | Buy |
145,800
+500
| +0.3% | +$8.33K | 0.02% | 683 |
|
|
2016
Q3 | $2.99M | Sell |
145,300
-33,100
| -19% | -$681K | 0.02% | 624 |
|
|
2016
Q2 | $5.46M | Buy |
178,400
+159,800
| +859% | +$4.89M | 0.04% | 427 |
|
|
2016
Q1 | $696K | Buy |
18,600
+2,800
| +18% | +$105K | 0.01% | 971 |
|
|
2015
Q4 | $682K | Sell |
15,800
-78,300
| -83% | -$3.38M | 0.01% | 978 |
|
|
2015
Q3 | $3.53M | Sell |
94,100
-203,570
| -68% | -$7.63M | 0.03% | 530 |
|
|
2015
Q2 | $10.1M | Sell |
297,670
-40,504
| -12% | -$1.38M | 0.09% | 260 |
|
|
2015
Q1 | $12M | Buy |
338,174
+1,084
| +0.3% | +$38.4K | 0.11% | 225 |
|
|
2014
Q4 | $11.5M | Buy |
337,090
+97,056
| +40% | +$3.31M | 0.12% | 240 |
|
|
2014
Q3 | $9.26M | Buy |
240,034
+155,579
| +184% | +$6M | 0.1% | 272 |
|
|
2014
Q2 | $3.29M | Buy |
84,455
+32,531
| +63% | +$1.27M | 0.04% | 530 |
|
|
2014
Q1 | $1.78M | Buy |
+51,924
| New | +$1.78M | 0.02% | 735 |
|
|
2013
Q4 | – | Sell |
-27,890
| Closed | -$655K | – | 1307 |
|
|
2013
Q3 | $655K | Sell |
27,890
-84,220
| -75% | -$1.98M | 0.01% | 898 |
|
|
2013
Q2 | $3.01M | Buy |
+112,110
| New | +$3.01M | 0.04% | 540 |
|